Nobo Medicine IPO is gaining momentum with new drug approvals on the horizon. Discover the latest updates here.
Read More

Nobo Medicine IPO is gaining momentum with new drug approvals on the horizon. Discover the latest updates here.
Read More
Cancer drug price cap raises questions about future medical device costs.
Read MorePrice control crackdown reveals 2,373 offences and RM11.6m in seizures.
Read MoreMethylprednisolone Acetate approval brings significant benefits to patients needing effective treatment options.
Read MoreRPG Life Sciences earnings show a net profit of Rs28.2 Cr driven by revenue growth. Learn more about their strategic…
Read More
Cancer drug price caps could significantly reduce treatment costs for patients.
Read More
China drug approval could reshape HBM Holdings' investment narrative. Discover the implications for investors and market trends.
Read MoreAurobindo Pharma stock growth reflects a strong 16.3% increase in Q1, showcasing the company's market resilience and potential.
Read More
Trade margin cap raises questions about drug pricing in India.
Read MoreAurobindo Pharma shares are in focus after USFDA approval for Perampanel tablets, raising investor interest and market potential.
Read More